silybin has been researched along with Chronic Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, S; Dai, X; Deng, X; Dong, J; Gao, X; Li, H; Lu, C; Niu, X; Tan, W; Wang, J; Wang, X; Zhang, Y | 1 |
1 other study(ies) available for silybin and Chronic Lung Injury
| Article | Year |
|---|---|
Silibinin in vitro protects A549 cells from Staphylococcus aureus-mediated injury and in vivo alleviates the lung injury of staphylococcal pneumonia.
Topics: Animals; Antioxidants; Bacterial Toxins; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Female; Hemolysin Proteins; Hemolysis; Humans; Inhibitory Concentration 50; Lung; Lung Injury; Mice; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Rabbits; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Silybin; Silymarin; Staphylococcus aureus | 2013 |